Northwest Biotherapeutics Inc (NASDAQ:NWBO)

8.27
Delayed Data
As of May 27
 +0.42 / +5.35%
Today’s Change
3.79
Today|||52-Week Range
9.45
+54.58%
Year-to-Date
No recent news for Northwest Biotherapeutics Inc.

Today’s Trading

Previous close7.85
Today’s open8.12
Day’s range7.85 - 8.29
Volume408,451
Average volume (3 months)576,753
Market cap$603.6M
Dividend yield--
Data as of 3:59pm ET, 05/27/2015

Growth & Valuation

Earnings growth (last year)-14.50%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+79.73%
P/E ratioNM
Price/Sales218.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RVNCRevance Therapeutics...+0.10+0.39%
--China Health Group I...-0.01-1.47%
OTICOtonomy Inc0.000.00%
OREXOrexigen Therapeutic...-0.02-0.30%
Data as of 4:00pm ET, 05/27/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$1.5M
Annual profit (last year)-$135.6M
Net profit margin-9,328.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer, Secretary &
Director
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers